BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18552627)

  • 1. Physical activity correlates with neurological impairment and disability in multiple sclerosis.
    Motl RW; Snook EM; Wynn DR; Vollmer T
    J Nerv Ment Dis; 2008 Jun; 196(6):492-5. PubMed ID: 18552627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal analysis of physical activity and symptoms as predictors of change in functional limitations and disability in multiple sclerosis.
    Motl RW; McAuley E
    Rehabil Psychol; 2009 May; 54(2):204-10. PubMed ID: 19469611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continued validation of the Symptom Inventory in multiple sclerosis.
    Motl RW; Schwartz CE; Vollmer T
    J Neurol Sci; 2009 Oct; 285(1-2):134-6. PubMed ID: 19592041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of follow-up and disease course].
    Roullet E
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1121-3. PubMed ID: 11787343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptoms and physical activity among adults with relapsing-remitting multiple sclerosis.
    Motl RW; McAuley E; Wynn D; Suh Y; Weikert M; Dlugonski D
    J Nerv Ment Dis; 2010 Mar; 198(3):213-9. PubMed ID: 20215999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Social anxiety in a multiple sclerosis clinic population.
    Poder K; Ghatavi K; Fisk JD; Campbell TL; Kisely S; Sarty I; Stadnyk K; Bhan V
    Mult Scler; 2009 Mar; 15(3):393-8. PubMed ID: 19028833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of walking mobility on the measurement of physical activity using accelerometry in multiple sclerosis.
    Snook EM; Motl RW; Gliottoni RC
    Clin Rehabil; 2009 Mar; 23(3):248-58. PubMed ID: 19218299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A reassessment of the plateauing relationship between T2 lesion load and disability in MS.
    Sormani MP; Rovaris M; Comi G; Filippi M
    Neurology; 2009 Nov; 73(19):1538-42. PubMed ID: 19794123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls.
    Goldman MD; Marrie RA; Cohen JA
    Mult Scler; 2008 Apr; 14(3):383-90. PubMed ID: 17942508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI as an outcome in multiple sclerosis clinical trials.
    Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
    Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis and brief moderate exercise. A randomised study.
    Bjarnadottir OH; Konradsdottir AD; Reynisdottir K; Olafsson E
    Mult Scler; 2007 Jul; 13(6):776-82. PubMed ID: 17613606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease progression in multiple sclerosis: combining physicians' and patients' perspectives?
    Kragt JJ; Nielsen JM; van der Linden FA; Polman CH; Uitdehaag BM
    Mult Scler; 2011 Feb; 17(2):234-40. PubMed ID: 20978037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clean intermittent self-catheterization in persons with multiple sclerosis: the influence of cognitive dysfunction.
    Vahter L; Zopp I; Kreegipuu M; Kool P; Talvik T; Gross-Paju K
    Mult Scler; 2009 Mar; 15(3):379-84. PubMed ID: 18987108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatigue and social impairment in multiple sclerosis: the role of patients' cognitive and behavioral responses to their symptoms.
    Skerrett TN; Moss-Morris R
    J Psychosom Res; 2006 Nov; 61(5):587-93. PubMed ID: 17084135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proxy measurements in multiple sclerosis: agreement on different patient-reported outcome scales.
    Sonder JM; Bosma LV; van der Linden FA; Knol DL; Polman CH; Uitdehaag BM
    Mult Scler; 2012 Feb; 18(2):196-201. PubMed ID: 21908479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multiple sclerosis: spontaneous course, natural history].
    Vukusic S; Moreau T; Bouhour F; Adeleine P; Confavreux C
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 1):753-6. PubMed ID: 11677394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verbal fluency deficits in multiple sclerosis.
    Henry JD; Beatty WW
    Neuropsychologia; 2006; 44(7):1166-74. PubMed ID: 16293271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerometry in persons with multiple sclerosis: measurement of physical activity or walking mobility?
    Weikert M; Motl RW; Suh Y; McAuley E; Wynn D
    J Neurol Sci; 2010 Mar; 290(1-2):6-11. PubMed ID: 20060544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatigue in multiple sclerosis: association with disease-related, behavioural and psychosocial factors.
    Trojan DA; Arnold D; Collet JP; Shapiro S; Bar-Or A; Robinson A; Le Cruguel JP; Ducruet T; Narayanan S; Arcelin K; Wong AN; Tartaglia MC; Lapierre Y; Caramanos Z; Da Costa D
    Mult Scler; 2007 Sep; 13(8):985-95. PubMed ID: 17468448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.